Abstract: The present invention pertains to a short acting NO donor for use in a method of reducing side effects of a treatment with said short acting NO donor, comprising administering during a defined time period a gradually increasing amount of said short acting NO donor in an intermitting manner. The present invention is further directed to a short acting NO donor for use in a method for the prevention or treatment of an arterial insufficiency, wherein the NO donor is administered in an intermitting manner, and wherein during the initial phase of the administration, the amount of said short acting NO donor is gradually increased.

Abstract: Use of glyceryl trinitrate (GTN) for treating traumatic edemas.

Abstract: Disclosed are methods of treatment and compositions containing at least one non-volatile silicone oil in combination with at least one spreading agent for use in the treatment of skin conditions in mammals typified by scales, plaques and scabs and associated with punctiform bleeding during the removal of scales, plaque or scabs. Preferred conditions are selected from the group consisting of seborrheic dermatitis, psoriasis, and cradle cap wherein the incidence of punctiform bleeding and formation of bloody tear points on the skin during removal of the scales is diminished or prevented.

Abstract: Use of glyceryl trinitrate (GTN) for treating traumatic edemas.

Abstract: Use of glyceryl trinitrate (GTN) for treating traumatic edemas.

Abstract: Use of glyceryl trinitrate (GTN) for treating traumatic edemas.

Abstract: Use of glyceryl trinitrate (GTN) for treating hematomas.

Abstract: Disclosed are methods of treatment and compositions containing at least one non-volatile silicone oil in combination with at least one spreading agent for use in the treatment of skin conditions in mammals typified by scales, plaques and scabs and associated with punctiform bleeding during the removal of scales, plaque or scabs. Preferred conditions are selected from the group consisting of seborrheic dermatitis, psoriasis, and cradle cap wherein the incidence of punctiform bleeding and formation of bloody tear points on the skin during removal of the scales is diminished or prevented.

Abstract: Compositions for combating ectoparasites, and particularly head lice and their nits comprise a low viscosity linear polysiloxane combined with a higher viscosity linear polysiloxane and at least one spreading agent. The low viscosity linear polysiloxane has a viscosity of less than 10 cSt and is present in a weight percentage of 30-40% of the formulation, while the higher viscosity linear polysiloxane has a viscosity of greater than 90 cSt and is present in a weight percentage of 35-65%.